Tisdag 26 November | 04:59:54 Europe / Stockholm

Prenumeration

Kalender

Tid*
2025-02-13 08:00 Bokslutskommuniké 2024
2024-11-07 - Kvartalsrapport 2024-Q3
2024-08-22 - Kvartalsrapport 2024-Q2
2024-05-15 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2024-05-14 - Årsstämma
2024-05-14 - Kvartalsrapport 2024-Q1
2024-02-21 - Extra Bolagsstämma 2024
2024-02-15 - Bokslutskommuniké 2023
2023-11-09 - Kvartalsrapport 2023-Q3
2023-09-28 - Extra Bolagsstämma 2023
2023-08-31 - Kvartalsrapport 2023-Q2
2023-05-12 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2023-05-11 - Årsstämma
2023-05-11 - Kvartalsrapport 2023-Q1
2023-02-16 - Bokslutskommuniké 2022
2022-12-09 - Extra Bolagsstämma 2022
2022-11-16 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-12 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2022-05-11 - Årsstämma
2022-05-11 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-23 - Extra Bolagsstämma 2021
2021-11-11 - Kvartalsrapport 2021-Q3
2021-08-19 - Kvartalsrapport 2021-Q2
2021-05-12 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2021-05-11 - Årsstämma
2021-05-11 - Kvartalsrapport 2021-Q1
2021-02-18 - Bokslutskommuniké 2020
2020-11-12 - Kvartalsrapport 2020-Q3
2020-08-20 - Kvartalsrapport 2020-Q2
2020-08-11 - Extra Bolagsstämma 2020
2020-05-15 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2020-05-14 - Årsstämma
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-20 - Bokslutskommuniké 2019
2019-11-14 - Kvartalsrapport 2019-Q3
2019-08-21 - Kvartalsrapport 2019-Q2
2019-08-16 - Extra Bolagsstämma 2019
2019-05-17 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2019-05-16 - Årsstämma
2019-05-16 - Kvartalsrapport 2019-Q1
2019-02-20 - Bokslutskommuniké 2018
2018-11-14 - Kvartalsrapport 2018-Q3
2018-08-21 - Kvartalsrapport 2018-Q2
2018-05-24 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2018-05-23 - Årsstämma
2018-05-23 - Kvartalsrapport 2018-Q1
2018-02-26 - Bokslutskommuniké 2017
2017-11-14 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-05-26 - X-dag ordinarie utdelning ACARIX 0.00 SEK
2017-05-24 - Årsstämma
2017-05-24 - Kvartalsrapport 2017-Q1
2017-02-23 - Bokslutskommuniké 2016

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Acarix är ett diagnostikbolag. Bolaget har utvecklat en teknologi som möjliggör identifiering av kranskärlssjukdomar. Bolagets produkt är ett icke-invasivt test som sätts med en lapp på patienten för att analysera ljud från hjärtat. Idag innehas verksamhet främst inom den nordiska marknaden. Bolaget grundades under 2009 som en avknoppning från Coloplast. Huvudkontoret ligger i Malmö.
2024-08-22 08:00:00

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 2024. The company achieved record-breaking patch sales and record-breaking gross profit, driven by the success of its new sales model coupled with key strategic initiatives involving commercial expansion and clinical activities. These results highlight the company’s growing market presence and commitment to innovation in the cardiac diagnostics space.

“I’m proud of the significant progress Acarix has made over the last quarter,” stated Aamir Mahmood, Acarix President and CEO. “The success we experienced in Q2, including record-breaking patch sales and a substantial increase in gross profit, is a clear indicator of our strategy’s effectiveness. This validates our commitment to innovation, operational excellence, and value creation as we continue to strengthen our market position with the CADScor System and expand our impact in cardiac diagnostics.”

Key Highlights

Second quarter 2024 compared to the same period in 2023

  • Revenue for the second quarter amounted to SEK 1,958 thousand (1,540), an increase of 27% compared to the same period last year. Revenue in the US increased by 34% compared to the same period last year.
  • Gross profit increased 38% to SEK 1,788 thousand (1,291), corresponding to a gross margin of 91% (84%) and an improvement of 7% points compared to the same period in 2023. US gross profit increased 59% with a gross margin increase on 9 points to 93%.
  • During the quarter a total of 15 (10) CADScor®Systems were installed at customers (2 sold / 13 on consignment) and 3,530 (2,682) patches were sold. In the US 1,260 patches were sold, an increase of 62% compared to the same period last year.
  • Operating costs amounted to SEK 18,368 thousand (23,186). One-time expenses amounting SEK 951 thosand. Excluding one-time expenses, cost reduction initiatives led to a 25% improvement compared to the same period last year.
  • Loss before tax amounted to SEK –16,661 thousand (–22,004).
  • Cashflow from operating activities amounted to SEK –15,258 thousand (-21,229).
  • Earnings per share amounted to SEK –0.02 (–0.05).

First half of 2024 compared to the same period in 2023

  • Revenue in the first half of the year amounted to SEK 3,509 thousand (3,495).
  • Gross profit amounted to SEK 3,202 thousand (2,978), corresponding to a gross margin of 91% (85%) and an improvement of 6% points compared to the same period in 2023.
  • During the first half of the year, 28 (22) CADScor Systems (5 sold / 23 on consignment) and 6,054 (5,217) patches were sold.
  • Operating expenses amounted to SEK 34,708 thousand (41,307). Non-recurring costs amounting SEK 1,497 thousand.
  • Loss before tax amounted to SEK –31,591 thousand (–38,484).
  • Cashflow from operating activities amounted to SEK -33,694 thousand (-41,840).
  • Cash and cash equivalents amounted to SEK 48,271 thousand (26,299). General pledging of bank deposits amounted to SEK 4,560 thousand.
  • Earnings per share amounted to SEK –0.04 (–0.08). No dilutive effects occurred.
  • Number of shares on the balance sheet date amounts to 973,170,178 (452,868,010).

Link to the report: https://www.acarix.com/for-investors/financial-reports-and-calendar